Sensei Biotherapeutics, Inc.
SNSECIK 0001829802 · Every Form 4 filed by insiders at this issuer. See financials →
Annual report (10-K)
Latest 10-K/A filed Jun 2, 2026. Sentiment + YoY language diff vs prior year. Read sections →
Signal:NeutralFull-doc fallback
Full filing:tone -0.0068
Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.
Recent 8-K announcements
Per-item disclosure feed. Item 2.02 is the earnings release.
Top insiders
Most active reporters at Sensei Biotherapeutics, Inc.
| Name | Roles | Filings |
|---|---|---|
| Gallagher Patrick Stephen | Officer | 4 |
| Holmen Bob | Director | 4 |
| Humer Kristian | Director | 4 |
| Ricks Thomas G | Director | 4 |
| Ringo William R | Director | 4 |
Top performers
Insiders ranked by realized 90-day signed return on their open-market trades at Sensei Biotherapeutics, Inc.. Minimum 3 scored trades. Returns are signed - a sale followed by a rally counts against the insider.
| # | Insider | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|---|
| 1 | Angermayer Christian | 4 | 50% | +14.4% | +14.4% | +29.5% | -0.6% |
| 2 | Apeiron Investment Group Ltd. | 4 | 50% | +14.4% | +14.4% | +29.5% | -0.6% |
| 3 | Presight Co-Invest Management, L.L.C. | 4 | 50% | +14.4% | +14.4% | +29.5% | -0.6% |
| 4 | Presight Sensei Co-Invest Fund, L.P. | 4 | 50% | +14.4% | +14.4% | +29.5% | -0.6% |
| 5 | Cambrian Biopharma Inc | 39 | 0% | -96.2% | -61.9% | -43.5% | -270.1% |
| 6 | Peyer James | 39 | 0% | -95.9% | -61.9% | -43.5% | -270.1% |
All filings
120 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|